Final patient vist done in trial testing Celeste light therapy for Parkinson’s
WHY IT MATTERS
Completion of this pivotal trial means Celeste light therapy could move closer to FDA approval, potentially offering Parkinson's patients a new non-drug treatment option if results are positive.
A company called Photopharmics has finished testing a light therapy device called Celeste for Parkinson's disease. The last patient in the large study has completed all their visits. This is an important step toward potentially getting the device approved for patients to use.
A pivotal clinical trial testing the light therapy device Celeste for Parkinson’s disease has wrapped up, with the last enrolled participant completing the study’s final visit. That’s according to a company press release from device developer Photopharmics, which called the completion of the large study a “key milestone.” Led by researchers at the University of […] The post Final patient vist done in trial testing Celeste light therapy for Parkinson’s appeared first on Pa